Match Better Cancer Treatments via Genomic BioMarkers Revenue and Competitors
Estimated Revenue & Valuation
- Match Better Cancer Treatments via Genomic BioMarkers's estimated annual revenue is currently $4.8M per year.
- Match Better Cancer Treatments via Genomic BioMarkers's estimated revenue per employee is $155,000
Employee Data
- Match Better Cancer Treatments via Genomic BioMarkers has 31 Employees.
- Match Better Cancer Treatments via Genomic BioMarkers grew their employee count by 7% last year.
Match Better Cancer Treatments via Genomic BioMarkers's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CHIEF MEDICAL ADVISOR & CO-FOUNDER | Reveal Email/Phone |
2 | VP Software Engineering / Software and Product Development | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | Director Business Development | Reveal Email/Phone |
5 | Director Engineering | Reveal Email/Phone |
6 | DIRECTOR OF SALES | Reveal Email/Phone |
7 | Director Clinical Reporting | Reveal Email/Phone |
8 | Associate Director Data Science, Head PawMatch | Reveal Email/Phone |
9 | Key Account Manager, Oncology | Reveal Email/Phone |
10 | chairman & co-founder | Reveal Email/Phone |
Match Better Cancer Treatments via Genomic BioMarkers Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Match Better Cancer Treatments via Genomic BioMarkers?
CureMatch®, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch's PreciGENE® Decision Support System guides oncologists in the selection of cancer drugs customized for individual patients based on their molecular tumor profile. CureMatch enables oncologists to become experts in personalized medicine by providing them with actionable intelligence towards advanced cancer treatment options.
keywords:N/A
N/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Match Better Cancer Treatments via Genomic BioMarkers News
But far from suggesting that more treatment always leads to ... All patients underwent genomic sequencing using the UCSF500 Cancer Gene...
New NCI-MATCH Treatment Arm Looks at dMMR & LAG-3-Positive Cancers ... the trial is open at more than 1,100 hospitals and cancer centers...
Below, we offer considerations for developing both complex genomic signature and single-gene biomarkers through clinical trial phases. In Phase...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 31 | N/A | N/A |
#2 | $3.6M | 31 | N/A | N/A |
#3 | $3.6M | 31 | N/A | N/A |
#4 | $4.8M | 31 | 11% | N/A |
#5 | $2.4M | 31 | -6% | $37M |